Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03307811 · ClinicalTrials.gov registry record · NA
Endoscopic Ultrasound Guided Liver Biopsy
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03307811 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 40 participants.
The verdict
NCT03307811, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a prospective study to determine the optimal technique for obtaining liver tissue with a smaller caliber (22 gauge) needle and whether a good core biopsy can be obtained without the use of suction and secondly to determine the diagnostic yield and safety of 22 g Fine Needle Biopsy needle for liver biopsy.
Interventions
- OTHER 22 gauge needle liver biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2018-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03307811
The ClinicalTrials.gov registry entry for NCT03307811 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 22 gauge needle liver biopsy is the first listed.
NCT03307811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03307811 about?
NCT03307811 is a clinical study titled "Endoscopic Ultrasound Guided Liver Biopsy". This is a prospective study to determine the optimal technique for obtaining liver tissue with a smaller caliber (22 gauge) needle and whether a good core biopsy can be obtained without the use of suction and secondly to determine the diagnostic yield and safety of 22 g Fine Needle Biopsy needle for...
What is the current status of trial NCT03307811?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-08-01. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT03307811?
The interventions under investigation include: 22 gauge needle liver biopsy (OTHER).
Who is sponsoring clinical trial NCT03307811?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.